Idecabtagene Vicleucel
2seventy bio,bms
[' pom ', 'multiple myeloma']
poster 2027: predictors of early progression after myeloma car t
very interesting findings and many questions from audience. to all the co-investigators #usmyelomacartconsortium #ash22 
Assistant Professor Hematology/BMT @Muschollings Plasma cell disorders/ BMT/Cellular Therapy. Opinions are my own and not employer’s